AVRO LIFE SCIENCE
A Universal Platform for Transdermal Drug Delivery
LEARN MORE
OUR Mission

OmniDerm™

Avro is a leading preclinical stage pharmaceutical company developing OmniDerm(™) - a platform transdermal technology for the passive delivery of small drug molecules. 


Avro’s novel polymer utilizes cutting-edge advances in biomaterials engineering and micro-encapsulation technology, to hold and deliver a wide range of drugs over a 1-7 day timespan, where transdermal delivery was previously thought to be impossible. 

Our mission is to improve patient health outcomes and quality of life through medication compliance and adherence afforded by effective drug delivery solutions.

To learn more, or chat about partnering, send us a note at: partnering@avrolifesci.com

OUR Solution

Accessible Transdermal Tech

One Size Fits All

One-size-fits-all versatile platform allowing for encapsulation and delivery of a wide variety of different small molecule drugs, inplace of existing “lock and key” patches available on the market, requiring a custom polymer for each drug.

Cost-effective Manufacturing

Cost-effective, tunable, and easily scalable manufacturing processes using easily sourced and non-irritant, non-toxic materials and known industrial methods. Results in a single layer, drug-in-adhesive, sweatproof, waterproof, non-irritant patch with few failure modes during production due to the polymer’s fundamental chemistry.

Eliminating Complex Systems

Relies on fundamental materials science breakthroughs enabled by recent advances in understanding of biomaterial interactions and microencapsulation methods. Eliminates the need for expensive microneedles, lock and key patches, and complex manufacturing processes, allowing Avro to succeed where pharma has failed

OUR TEAM

Shakir Lakhani
Co-founder, CEO
Keean Sarani
Co-founder, COO
Frank LaRonde MD, PhD
Senior Scientist
Dr. Scott Campbell
Senior Scientist
Shirley Wang
Research Associate
Drew Davidson
Research Associate
Andrew Mendonca
Research Associate

Advisors

Dr. Christopher Rhodes
CEO, Drug Delivery Experts
Dr. Frank Gu
Canada Research Chair in Targeted Drug Delivery
Dr. Orlando Lopez
Ex-FDA Lead Reviewer,
Ex-Mayo Clinic
Dr. Elizabeth Iorns
CEO of Science Exchange, Stanford Med METRICS Advisory Board member, YC Expert
Dr. Maleek Jamal
Ex-Lead, BCG Healthcare Practice
Dr. Muhammad Mamdani
Ex-Director, Pfizer
Who Supports us

Partners

Y CombinatorY CombinatorY CombinatorY CombinatorY CombinatorY Combinator
GET IN TOUCH

Contact Us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.